Publication | Closed Access

Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent

ThrombopoiesisNanomedicineThrombosisEngineeringBlood PlateletMedicineTheranosticsAnticoagulantThrombus-specific Theranostic NanocompositeBiomedical EngineeringContrast AgentPlatelet AntagonistPharmacologyThrombolytic DrugBiomolecular Engineering